Rofecoxib
CAS No. | 162011-90-7 | Cat. No. | BCP03619 |
Name | Rofecoxib | ||
Synonyms | MK 966;Vioxx;MK966;MK-966; MK0966; MK0966; MK 0966; | ||
Formula | C17H14O4S | M. Wt | 314.36 |
Description | Rofecoxib is a synthetic, nonsteroidal derivative of phenyl-furanone with antiinflammatory, antipyretic and analgesic properties and potential antineoplastic properties. Rofecoxib binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in an inhibition of the conversion of arachidonic acid to prostaglandins. COX-related metabolic pathways may represent key regulators of cell proliferation and neo-angiogenesis. Some epithelial tumor cell types overexpress pro-angiogenic COX-2. Rofecoxib was used as an anti-inflammatory analgesic which has now been withdrawn from the market because of its association with cardiovascular problems. | ||
Pathways | Neuro Signaling Pathway | ||
Targets | COX |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.